Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
Ruiwen Zhang(Institute of Pharmacology)
Cited by 23
Related Papers
The MDM2-p53 pathway revisited
|Journal of Biomedical Research|2013|410
<i>In vitro</i> and <i>In vivo</i> Anticancer Activity of Novel Synthetic Makaluvamine Analogues
|Clinical Cancer Research|2009|65
Recent Advances in Validating MDM2 as a Cancer Target
|Anti-Cancer Agents in Medicinal Chemistry|2009|48